The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Substance use among criminal offenders constitutes a major public health problem and is tied to negative consequences for offenders, their families, and their communities. One of the direst of these consequences is repeated incarceration; thus, interventions that reduce criminal recidivism are needed. Forensic populations are often viewed with considerable therapeutic pessimism. However, offenders exhibit heterogeneity in personality traits, and the assessment of individual differences among offenders may provide valuable information that guides the use of psychotherapeutic interventions. Among offenders, psychopathy has emerged as an important personality construct for the understanding of violence and criminal recidivism. Moreover, core traits of psychopathy such as lack of empathy, deceitfulness, and lack of remorse may have negative implications for the efficacy of psychosocial interventions. A foundational premise of the present work is that understanding the moderating role of psychopathic traits on substance use treatment outcomes among offenders is essential to determining what works, and for whom. The current proposal is a Phase II randomized clinical trial that aims to examine the impact of psychopathic traits on the efficacy of a brief substance use intervention for offenders in a jail diversion program. Hypotheses that will be examined include: 1) that a Motivational Interviewing (MI) - based treatment will reduce substance use and related consequences relative to a Standard Care only condition, 2) that the reduction in substance use in the intervention group will mediate a reduction in later criminal recidivism relative to the Standard Care condition, and 3) that core psychopathic traits will moderate the efficacy of the intervention such that individuals with lower levels of these traits will derive greater benefits with regard to decreased substance use, decreased drug use consequences, and decreased criminal recidivism at a one-year follow-up.
| Condition | Intervention | Phase |
|---|---|---|
|
Substance Use Psychopathy |
Behavioral: motivational enhancement therapy Other: standard care |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | The Impact of Psychopathic Traits on the Efficacy of a Brief Intervention for Substance Use |
- criminal recidivism [ Time Frame: one year ] [ Designated as safety issue: No ]criminal charges within one year
- substance use [ Time Frame: six months ] [ Designated as safety issue: No ]using timeline followback data, use of substances will be assessed
| Estimated Enrollment: | 120 |
| Study Start Date: | August 2009 |
| Estimated Study Completion Date: | July 2014 |
| Estimated Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: brief therapy
motivational enhancement therapy for substance use
|
Behavioral: motivational enhancement therapy
Four 45-minute MET sessions
Other Name: SBIRT
|
|
Placebo Comparator: Standard Care
standard care
|
Other: standard care
standard care
|
Detailed Description:
Substance use among criminal offenders constitutes a major public health problem and is tied to negative consequences for offenders, their families, and their communities. One of the direst of these consequences is repeated incarceration; thus, interventions that reduce criminal recidivism are needed. Forensic populations are often viewed with considerable therapeutic pessimism. However, offenders exhibit heterogeneity in personality traits, and the assessment of individual differences among offenders may provide valuable information that guides the use of psychotherapeutic interventions. Among offenders, psychopathy has emerged as an important personality construct for the understanding of violence and criminal recidivism. Moreover, core traits of psychopathy such as lack of empathy, deceitfulness, and lack of remorse may have negative implications for the efficacy of psychosocial interventions. A foundational premise of the present work is that understanding the moderating role of psychopathic traits on substance use treatment outcomes among offenders is essential to determining what works, and for whom. The current proposal is a Phase II randomized clinical trial that aims to examine the impact of psychopathic traits on the efficacy of a brief substance use intervention for offenders in a jail diversion program. Hypotheses that will be examined include: 1) that a Motivational Interviewing (MI) - based treatment will reduce substance use and related consequences relative to a Standard Care only condition, 2) that the reduction in substance use in the intervention group will mediate a reduction in later criminal recidivism relative to the Standard Care condition, and 3) that core psychopathic traits will moderate the efficacy of the intervention such that individuals with lower levels of these traits will derive greater benefits with regard to decreased substance use, decreased drug use consequences, and decreased criminal recidivism at a one-year follow-up. This work has the potential to provide important data regarding which individuals can benefit from a brief intervention for substance use. Such data will inform the effective and efficient allocation of treatment resources for substance using offenders.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- In local pretrial services program; English speaking
Exclusion Criteria:
- Psychosis
Contacts and Locations| Contact: Marc T. Swogger, Ph.D. | 585-275-7418 | marc_swogger@urmc.rochester.edu |
| United States, New York | |
| Pretrial Services, Inc. | Recruiting |
| Rochester, New York, United States, 14642 | |
| Principal Investigator: Marc T. Swogger, Ph.D. | |
| Principal Investigator: | Marc T. Swogger, Ph.D. | University of Rochester |
More Information
No publications provided
| Responsible Party: | MarcSwogger, Assistant Professor, University of Rochester |
| ClinicalTrials.gov Identifier: | NCT01532934 History of Changes |
| Other Study ID Numbers: | 28780 |
| Study First Received: | January 31, 2012 |
| Last Updated: | February 10, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by University of Rochester:
|
substance use psychopathy motivational enhancement criminal recidivism |
Additional relevant MeSH terms:
|
Antisocial Personality Disorder Personality Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 18, 2013